surmount-1 tirzepatide weight loss non-diabetic Study Finds Individuals with Obesity Lost up to 22.5% of their Body when Taking Read now: The SURPASS-EARLY trial

Once at a therapeutic maintenance dose, this may increase to 4 to 8 pounds, though individual results vary

Managing GI Side Effects# Regardless of the specific drug, several strategies can mitigate GI adverse events: Slow titration: Following or extending the recommended dose escalation schedule Dietary modification: Smaller meals, avoiding high-fat foods, eating slowly Timing: Taking the injection (or pill) at a consistent time, often in the evening Hydration: Maintaining adequate fluid intake to offset effects of reduced food intake Anti-emetics: Short-term use during dose escalation if needed What to Watch# Ecnoglutide and CT-388 Phase 3 data -- Will the tolerability advantage of biased agonism hold in larger, longer trials

[4] [5] How Long Diarrhoea Typically Lasts on Retatrutide Diarrhoea is most pronounced during dose escalation and may begin to settle within one to two weeks of reaching a stable dose, though this estimate is based on class experience rather than retatrutide-specific data

To help, the pancreas, an internal organ located in the abdomen, creates insulin

The point is that a triple agonist needs careful evaluation before broad use

Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials